论文部分内容阅读
关于减敏疗法(Hyposensitization)的潜在危险性,迄今各家报告结果不一。本文研究结果发现,应用霉菌浸出液作减敏治疗对某些哮喘儿童可能是有害的。38例哮喘患儿依据点刺法皮试结果阳性和放射变应原吸附试验(RAST)结果阳性;或支气管吸入激发试验阳性,而确诊为对霉菌过敏。并给予混合霉菌浸出液(内含等量当地最常见的Herbarum分支霉菌和lridis链格孢霉菌作了为期3 1/2年的减敏治疗。其中
The potential dangers of hyposensitization have so far been mixed. The results of this study found that the use of mold extract for desensitization may be detrimental to some asthmatic children. Thirty-eight children with asthma were positive for prick test and positive for radiological allergen adsorption test (RAST), or were positive for bronchial inhalation challenge test and diagnosed as allergic to mold. And given a mixture of mold leachate (containing equal parts of the most common Mybarum Herbarum and lridis Alternaria so a period of 3/2 years of desensitization treatment.